Diabetes drug trial aims to protect MS Patients' brains
NCT ID NCT07497399
Summary
This study is testing whether a medication currently used for diabetes can slow down brain and eye nerve damage in people with multiple sclerosis (MS). Researchers will give 120 participants either the study drug or a placebo for about two years and use brain scans to measure changes in brain volume. The goal is to see if this drug can reduce inflammation and protect the nervous system from further damage in MS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.